Cost Analysis of Voriconazole Versus Liposomal Amphotericin B and Caspofungin for Primary Therapy of Invasive Aspergillosis Among High-Risk Hematologic Cancer Patients in Saudi Arabia
Value in Health - United Kingdom
doi 10.1016/j.jval.2015.09.2433
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2015
Authors
Publisher
Elsevier BV